Electromed (NYSE:ELMD) Incorporated (ticker: ELMD), a medical device company, has reported a significant revenue increase for the fourth quarter and the full fiscal year 2024. The company achieved ...

Lake Street analyst Brooks O’Neil maintained a Buy rating on Electromed (ELMD – Research Report) today and set a price target of $26.00. The company’s shares closed yesterday at $16.05.

Greetings, and welcome to the Electromed Fourth Quarter 2024 Earnings Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation.

Electromed shares rose after the medical-equipment maker posted quarterly earnings ahead of market expectations. Shares of the maker of airway-clearance devices rose 7.2% to $17.21 in after-hours ...

NEW PRAGUE, Minn., August 27, 2024--(BUSINESS WIRE)--Electromed, Inc. ("Electromed") (NYSE American: ELMD), a leader in innovative airway clearance technologies ...

Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months (“Q4 FY 2024”) and full ...

“I’m extremely pleased with the Electromed team’s performance in fiscal 2024, as we continued to drive double-digit top line growth coupled with strong operating leverage,” said Jim ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...